Health Affairs October 3, 2025
Editor’s Note
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation. Articles in this topic offer timely analyses of regulatory, legislative, and judicial developments in health policy under the Trump-Vance Administration and the 119th Congress. Health Affairs Forefront alone reviews all submissions then selects, edits, and publishes them only if they meet Forefront’s editorial standards.
On September 30, 2025, Judge Matthew Kacsmaryk transferred a long-standing legal challenge over the Food and Drug Administration’s (FDA’s) regulation of mifepristone from his courtroom in the northern district of Texas to a new courtroom in the eastern district of Missouri. His Texas...
Today's Sponsors
Today's Sponsor